Occupational asthma is a type of asthma caused or worsened by exposure to substances in the workplace, such as dust, chemical fumes, gases, or biological agents. Workers in industries like manufacturing, agriculture, healthcare, and cleaning services are particularly at risk. Symptoms often include coughing, wheezing, chest tightness, and shortness of breath, which may worsen during work hours and improve when away from the workplace. Early diagnosis of occupational asthma relies on detailed occupational histories, pulmonary function testing, and sometimes specific inhalation challenge tests to establish a clear link between symptoms and workplace exposures. Recognizing early signs is crucial to prevent chronic airway remodeling and irreversible lung damage. Workplace interventions and preventive measures are essential to reduce exposure and safeguard respiratory health.
Management focuses on minimizing exposure while optimizing symptom control and preserving long-term lung function. Engineering controls, protective equipment, and substitution of hazardous substances help reduce inhalation of irritants. Pharmacologic treatment, including inhaled corticosteroids and bronchodilators, can manage inflammation and relieve symptoms. Pulmonary rehabilitation, patient education on trigger avoidance, and routine monitoring are important for maintaining lung health. Collaboration between occupational health specialists, pulmonologists, and employers ensures that preventive measures and individualized care plans are effectively implemented. By combining clinical management with workplace safety strategies, patients can maintain respiratory function and continue working while minimizing disease progression.
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Susceptibility to SARS-CoV-2 infection and nasal air conditioning ability
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Comparative evaluation of DECAF and BAP 65 scores in predicting outcomes of COPD exacerbations among in patients at Vicente Sotto Memorial Medical Center
Allanys Joy Q Pino, Vicente Sotto Memorial Medical Center, Philippines
Title :
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States
Title : Personalized and precision Medicine (PPM) as a unique healthcare model through biodesign driven and inspired biotech, translational applications and pulmonology related marketing to secure the human healthcare, wellness and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation